The enigmatic protein kinase Cδ: Complex roles in cell proliferation and survival

FASEB Journal

Volumn 18, Issue 6, 2004, Pages 627-636

  Jackson, Desmond N ^a   Foster, David A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cell cycle; Tumor promotion; Tumor suppressor; Tyrosine kinase

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C DELTA; RAF PROTEIN; RAS PROTEIN;

APOPTOSIS; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASMS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; TUMOR SUPPRESSOR PROTEINS; TYROSINE;

PYRONIA TITHONUS;

EID: 1842454982     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.03-0979rev     Document Type: Review

References (97)

1. Yupsa, S. H., and Poirier, M. C. (1988) Chemical carcinogenesis: from animal models to molecular models in one decade. Adv. Cancer Res. 50, 25-70
2. Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., and Nishizuka, Y. (1983) Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J. Biol. Chem. 258, 11442-11445
3. Kikkawa, U., Kishimoto, A., and Nishizuka, Y. (1989) The protein kinase C family: heterogeneity and its implications. Annu. Rev. Biochem. 58, 31-44
4. Lee, H. W., Smith, L., Pettit, G. R., Vinitsky, A., and Smith, J. B. (1996) Ubiquitination of protein kinase C-α and degradation by the proteasome. J. Biol. Chem. 271, 20973-20976
5. Lu, Z., Liu, D., Hornia, A., Devonish, W., Pagano, M., and Foster, D. A. (1998) Activation of protein kinase C triggers its ubiquitination and degradation. Mol. Cell. Biol. 18, 839-845
6. Brodie, C., and Blumberg, P. M. (2003) Regulation of cell apoptosis by protein kinase C δ. Apoptosis 8, 19-27
7. Leitges, M., Mayr, M., Braun, U., Mayr, U., Li, C., Pfister, G., Ghaffari-Tabrizi, N., Baier, G., Hu, Y., and Xu, Q. (2001) Exacerbated vein graft arteriosclerosis in protein kinase Cδ-null mice. J. Clin. Invest. 108, 1505-1512
8. Miyamoto, A., Nakayama, K., Imaki, H., Hirose, S., Jiang, Y., Abe, M., Tsukiyama, T., Nagahama, H., Ohno, S., Hatakeyama, S., et al. (2002) Increased proliferation of B cells and autoimmunity in mice lacking protein kinase C δ. Nature (London) 416, 865-869
9. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (London) 356, 215-221
10. Watanabe, T., Ono, Y., Taniyama, Y., Hazama, K., Igarashi, K., Ogita, K., Kikkawa, U., and Nishizuka, Y. (1992) Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-δ subspecies. Proc. Natl. Acad. Sci. USA 89, 10159-10163
11. Mischak, H., Goodnight, J., Kolch, W., Martiny-Baron, G., Schaechtle, C., Kazanietz, M. G., Blumberg, P. M., Pierce, J. H., and Mushinski, J. F. (1993) Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268, 6090-6096
12. Acs, P., Beheshti, M., Szallasi, Z., Li, L., Yuspa, S. H., and Blumberg, P. M. (2000) Effect of a tyrosine 155 to phenylalanine mutation of protein kinase C δ on the proliferative and tumorigenic properties of NIH 3T3 fibroblasts. Carcinogenesis 21, 887-891
13. Braun, M. U., and Mochly-Rosen, D. (2003) Opposing effects of δ- and ζ-protein kinase C isozymes on cardiac fibroblast proliferation: use of isozyme-selective inhibitors. J. Mol. Cell. Cardiol. 35, 895-903
14. Kambhampati, S., Li, Y., Verma, A., Sassano, A., Majchrzak, B., Deb, D. K., Parmar, S., Giafis, N., Kalvakolanu, D. V., Rahman, A., et al. (2003) Activation of protein kinase C-δ (PKC-δ) by All-trans-retinoic acid. J. Biol. Chem. 278, 32544-32551
15. Fukumoto, S., Nishizawa, Y., Hosoi, M., Koyama, H., Yamakawa, K., Ohno, S., and Morii, H. (1997) Protein kinase C δ inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J. Biol. Chem. 272, 13816-13822
16. Harrington, E. O., Loffler, J., Nelson, P. R., Kent, K. C., Simons, M., and Ware, J. A. (1997) Enhancement of migration by protein kinase Cα and inhibition of proliferation and cell cycle progression by protein kinase Cδ in capillary endothelial cells. J. Biol. Chem. 272, 7390-7397
17. Kip1. J. Biol. Chem. 274, 20805-20811
18. Stetak, A., Lankenau, A., Vantus, T., Csermely, P., Ullrich, A., and Keri, G. (2001) The antitumor somatostatin analogue TT-232 induces cell cycle arrest through PKCδ and c-Src. Biochem. Biophys. Res. Commun. 285, 483-488
19. WAF/Cip1 expression and growth inhibition of A431 cells. Biochem. Biophys. Res. Commun. 250, 430-435
20. Cip1 by modulating the protein kinase Cδ pathway in vascular smooth muscle cells. J. Biol. Chem. 276, 47650-47657
21. WAF1/CIP1 induction. Cancer Lett. 172, 43-53
22. Soh, J. W., and Weinstein, I. B. (2003) Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J. Biol. Chem. 278, 34709-34716
23. Page, K., Li, J., Corbit, K. C., Rumilla, K. M., Soh, J. W., Weinstein, I. B., Albanese, C., Pestell, R. G., Rosner, M. R., and Hershenson, M. B. (2002) Regulation of airway smooth muscle cyclin D1 transcription by protein kinase C-δ. Am. J. Respir. Cell Mol. Biol. 27, 204-213
24. Kitamura, K., Mizuno, K., Etoh, A., Akita, Y., Miyamoto, A., Nakayama, K., and Ohno, S. (2003) The second phase activation of protein kinase C δ at late G1 is required for DNA synthesis in serum-induced cell cycle progression. Genes Cells 8, 311-324
25. Griffiths, G., Garrone, B., Deacon, E., Owen, P., Pongracz, J., Mead, G., Bradwell, A., Watters, D., and Lord, J. (1996) The polyether bistratene A activates protein kinase C-δ and induces growth arrest in HL60 cells. Biochem. Biophys. Res. Commun. 222, 802-808
26. Watters, D., Garrone, B., Coomer, J., Johnson, W. E., Brown, G., and Parsons, P. (1998) Stimulation of melanogenesis in a human melanoma cell line by bistratene A. Biochem. Pharmacol. 55, 1691-1699
27. Li, W., Jiang, Y. X., Zhang, J., Soon, L., Flechner, L., Kapoor, V., Pierce, J. H., and Wang, L. H. (1998) Protein kinase C-δ is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation. Mol. Cell. Biol. 18, 5888-5898
28. Pal, S., Claffey, K. P., Dvorak, H. F., and Mukhopadhyay, D. (1997) The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J. Biol. Chem. 272, 27509-27512
29. Datta, K., Nambudripad, R., Pal, S., Zhou, M., Cohen, H. T., and Mukhopadhyay, D. (2000) Inhibition of insulin-like growth factor-1-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer. J. Biol. Chem. 275, 20700-20706
30. Liu, J.-P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I and type 1 IGF receptor. Cell 75, 59-72
31. Accili, D., Drago, J., Lee, E. J., Johnson, M. D., Cool, M. H., Salvatore, P., Asico, L. D., Jose, P. A., Taylor, S. I., and Westphal, H. (1996) Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12, 106-109
32. Foncea, R., Galvez, A., Perez, V., Morales, M. P., Calixto, A., Melendez, J., Gonzalez-Jara, F., Diaz-Araya, G., Sapag-Hagar, M., Sugden, P. H., et al. (2000) Extracellular regulated kinase, but not protein kinase C, is an antiapoptotic signal of insulin-like growth factor-1 on cultured cardiac myocytes. Biochem. Biophys. Res. Commun. 273, 736-744
33. Liao, L., Ramsay, K., and Jaken, S. (1994) Protein kinase C isozymes in progressively transformed rat embryo fibroblasts. Cell Growth Differ. 5, 1185-1194
34. Kiley, S. C., Clark, K. J., Duddy, S. K., Welch, D. R., and Jaken, S. (1999) Increased protein kinase Cδ in mammary tumor cells: relationship to transformation and metastatic progression. Oncogene 18, 6748-6757
35. Kiley, S. C., Clark, K. J., Goodnough, M., Welch, D. R., and Jaken, S. (1999) Protein kinase Cδ involvement in mammary tumor cell metastasis. Cancer Res. 59, 3230-3238
36. Kruger, J. S., and Reddy, K. B. (2003) Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Mol. Cancer Res. 1, 801-809
37. McCracken, M. A., Miraglia, L. J., McKay, R. A., and Strobl, J. S. (2003) Protein kinase C δ is a prosurvival factor in human breast tumor cell lines. Mol. Cancer Ther. 2, 273-281
38. Kumar, V., Pandey, P., Sabatini, D., Kumar, M., Majumder, P. K., Bharti, A., Carmichael, G., Kufe, D., and Kharbanda, S. (2000) Functional interaction between RAFT1/FRAP/mTOR and protein kinase C δ in the regulation of cap-dependent initiation of translation. EMBO J. 19, 1087-1097
39. Schmelzie, T., and Hall, M. N. (2000) TOR, a controller of cell growth. Cell 103, 253-262
40. Keshamouni, V. G., Mattingly, R. R., and Reddy, K. B. (2002) Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 and PKC-δ. J. Biol. Chem. 277, 22558-22565
41. Ueda, Y., Hirai, S., Osada, S., Suzuki, A., Mizuno, K., and Ohno, S. (1996) Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J. Biol. Chem. 271, 23512-23519
42. Corbit, K. C., Foster, D. A., and Rosner, M. R. (1999) Protein kinase Cδ mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells. Mol. Cell. Biol. 19, 4209-4218
43. Jackson, T. A., Schweppe, R. E., Koterwas, D. M., and Bradford, A. P. (2001) Fibroblast growth factor activation of the rat PRL promoter is mediated by PKCδ. (2001). Mol. Endocrinol. 15, 1517-1528
44. Zang, Q., Lu, Z., Curto, M., Barile, N., Shalloway, D., and Foster, D. A. (1997) Interaction between v-Src and protein kinase C δ in v-Src-transformed fibroblasts. J. Biol. Chem. 272, 13275-13280
45. Blake, R. A., Garcia-Paramio, P., Parker, P. J., and Courtneidge, S. A. (1999) Src promotes PKCδ degradation. Cell Growth Differ. 10, 231-241
46. Shanmugam, M., Krett, N. L., Peters, C. A., Maizels, E. T., Murad, F. M., Kawakatsu, H., Rosen, S. T., and Hunzicker-Dunn, M. (1998) Association of PKC δ and active Src in PMA-treated MCF-7 human breast cancer cells. Oncogene 16, 1649-1654
47. Song, J. S., Swann, P. G., Szallasi, Z., Blank, U., Blumberg, P. M., and Rivera, J. (1998) Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-δ with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-δ. Oncogene 16, 3357-3368
48. Zhong, M., Lu, Z., Abbas, T., Hornia, A., Chatakondu, K., Barile, N., Kaplan, P., and Foster, D. A. (2001) Novel tumor-promoting property of tamoxifen. Cell Growth Differ. 12, 187-192
49. Kronfeld, I., Kazimirsky, G., Lorenzo, P. S., Garfield, S. H., Blumberg, P. M., and Brodie, C. (2000) Phosphorylation of PKCδ on distinct tyrosine residues regulates specific cellular functions. J. Biol. Chem. 275, 35491-35498
50. Yuan, Z. M., Utsugisawa, T., Ishiko, T., Nakada, S., Huang, Y., Kharbanda, S., Weichselbaum, R., and Kufe, D. (1998) Activation of protein kinase Cδ by the c-Abl tyrosine kinase in response to ionizing radiation. Oncogene 16, 1643-1648
51. Gschwendt, M. (1999) Protein kinase C δ. Eur. J. Biochem. 259, 555-564
52. Biscardi, J. S., Tice, D. A., and Parsons, S. J. (1999) c-Src, receptor tyrosine kinases, and human cancer. Adv. Cancer Res. 76, 61-119
53. Ha gene in murine keratinocytes induces tyrosine phosphorylation and reduced activity of protein kinase C δ. J. Biol. Chem. 268, 26079-26081
54. Gschwendt, M., Kielbassa, K., Kittstein, W., and Marks, F. (1994) Tyrosine phosphorylation and stimulation of protein kinase C δ from porcine spleen by src in vitro. Dependence on the activated state of protein kinase C δ. FEBS Lett. 347, 85-89
55. Li, W., Mischak, H., Yu, J. C., Wang, L. M., Mushinski, J. F., Heidaran, M. A., and Pierce, J. H. (1994) Tyrosine phosphorylation of protein kinase C-δ in response to its activation. J. Biol. Chem. 269, 2349-2352
56. Li, W., Yu, J. C., Michieli, P., Beeler, J. F., Ellmore, N., Heidaran, M. A., and Pierce J. H. (1994) Stimulation of the platelet-derived growth factor β receptor signaling pathway activates protein kinase C-δ. Mol. Cell. Biol. 14, 6727-6735
57. Li, W., Chen, X. H., Kelley, C. A., Alimandi, M., Zhang, J. Chen, Q., Bottaro, D. P., and Pierce, J. H. (1996) Identification of tyrosine 187 as a protein kinase C-δ phosphorylation site. J. Biol. Chem. 271, 26404-26409
58. Denning, M. F., Dlugosz, A. A., Threadgill, D. W., Magnuson, T., and Yuspa, S. H. (1996) Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C δ. J. Biol. Chem. 271, 5325-5331
59. Crosby, D., and Poole, A. W. (2003) Physical and functional interaction between protein kinase C δ and Fyn tyrosine kinase in human platelets. J. Biol. Chem. 278, 24533-24541
60. Szallasi, Z., Denning, M. F., Chang, E. Y., Rivera, J., Yuspa, S. H., Lehel, C., Olah, Z., Anderson, W. B., and Blumberg, P. M. (1995) Development of a rapid approach to identification of tyrosine phosphorylation sites: application to PKC δ phosphorylated upon activation of the high affinity receptor for IgE in rat basophilic leukemia cells. Biochem. Biophys. Res. Commun. 214, 888-894
61. Haleem-Smith, H., Chang, E. Y., Szallasi, Z., Blumberg, P. M., and Rivera, J. (1995) Tyrosine phosphorylation of protein kinase C-δ in response to the activation of the high-affinity receptor for immunoglobulin E modifies its substrate recognition. Proc. Natl. Acad. Sci. USA 92, 9112-9116
62. Sun, X., Wu, F., Datta, R., Kharbanda, S., and Kufe, D. (2000) Interaction between protein kinase C δ and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J. Biol. Chem. 275, 7470-7473
63. Konishi, H., Tanaka, M., Takemura, Y., Matsuzaki, H., Ono, Y., Kikkawa, U., and Nishizuka, Y. (1997) Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc. Natl. Acad. Sci. USA 94, 11233-11237
64. Konishi, H., Yamauchi, E., Taniguchi, H., Yamamoto, T., Matsuzaki, H., Takemura, Y., Ohmae, K., Kikkawa, U., and Nishizuka, Y. (2001) Phosphorylation sites of protein kinase Cδ in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc. Natl. Acad. Sci. USA 98, 6587-6592
65. Blass, M., Kronfeld, I., Kazimirsky, G., Blumberg, P. M., and Brodie, C. (2002) Tyrosine phosphorylation of protein kinase Cδ is essential for its apoptotic effect in response to etoposide. Mol. Cell. Biol. 22, 182-195
66. Joseloff, E., Cataisson, C., Aamodt, H., Ocheni, H., Blumberg, P., Kraker, A. J., and Yuspa, S. H. (2002) Src family kinases phosphorylate protein kinase C δ on tyrosine residues and modify the neoplastic phenotype of skin keratinocytes. J. Biol. Chem. 277, 12318-12323
67. Lu, Z., Hornia, A., Jiang, Y.-W., Frankel, P., Zang, Q., Ohno, S., and Foster, D. A. (1997) Tumor-promotion by depleting cells of protein kinase C δ. Mol. Cell. Biol. 17, 3418-3428
68. Hornia, A., Lu, Z., Sukezane, T., Zhong, M., Joseph, T., Frankel, P., and Foster, D. A. (1999) Antagonistic effects of protein kinase C α and δ on both transformation and phospholipase D activity mediated by the EGF receptor. Mol. Cell. Biol. 19, 7672-7680
69. Reddig, P. J., Dreckschmidt, N. E., Ahrens, H., Simsiman, R., Tseng, C. P., Zou, J., Oberley, T. D., and Verma, A. K. (1999) Transgenic mice overexpressing protein kinase Cδ in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 59, 5710-5718
70. Gschwendt, M., Furstenberger, G., Leibersperger, H., Kittstein, W., Lindner, D., Rudolph, C., Barth, H., Kleinschroth, J., Marme, D., and Schachtele, C. (1995) Lack of an effect of novel inhibitors with high specificity for protein kinase C on the action of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate on mouse skin in vivo. Carcinogenesis 16, 107-111
71. Szallasi, Z., Denning, M. F., Smith, C. B., Dlugosz, A. A., Yuspa, S. H., Pettit, G. R., and Blumberg, P. M. (1994) Bryostatin 1 protects protein kinase C-δ from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Mol. Pharmacol. 46, 840-850
72. Hennings, H., Blumberg, P. M., Pettit, G. R., Herald, C. L., Shores, R., and Yuspa, S. H. (1987) Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis 8, 1343-1346
73. Gschwendt, M., Muller, H.-J., Kielbassa, K., Zang, R., Kittstein, W., Rincke, G., and Marks, F. (1994) Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199, 63-98
74. Dietrich, C., Gumpert, N., Heit, I., Borchert-Stuhltrager, M., Oesch, F., and Wieser, R. (2001) Rottlerin induces a transformed phenotype in human keratinocytes. Biochem. Biophys. Res. Commun. 282, 575-579
75. Perletti, G. P., Marras, E., Concari, P., Piccinini, F., and Tashjian, A. H., Jr. (1999) PKCδ acts as a growth and tumor suppressor in rat colonic epithelial cells. Oncogene 18, 1251-1256
76. Heit, I., Wieser, R. J., Herget, T., Faust, D., Borchert-Stuhltrager, M., Oesch, F., and Dietrich, C. (2001) Involvement of protein kinase Cδ in contact-dependent inhibition of growth in human and murine fibroblasts. Oncogene 20, 5143-5154
77. DeVries, T. A., Neville, M. C., and Reyland, M. E. (2002) Nuclear import of PKCδ is required for apoptosis: identification of a novel nuclear import sequence. EMBO J. 21, 6050-6060
78. Land, H., Parada, L. F., and Weinberg, R. A. (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (London) 304, 596-602
79. Dotto, G. P., Parada, L. F., and Weinberg, R. A. (1985) Specific growth response of ras-transformed embryo fibroblasts to tumour promoters. Nature (London) 318, 472-475
80. Pardee, A. B. (1974) A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA 71, 1286-1290
81. Ho, A., and Dowdy, S. F. (2002) Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes. Curr. Opin. Genet. Dev. 12, 47-52
82. Zetterberg, A., Larsson, O., and Wiman, K. G. (1995) What is the restriction point? Curr. Opin. Cell Biol. 7, 835-842
83. Hulleman, E., and Boonstra, J. (2001) Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell. Mol. Life Sci. 58, 80-93
84. Lundberg, A. S., and Weinberg, R. A. (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18, 753-761
85. Pipas, J. M., and Levine, A. J. (2001) Role of T antigen interactions with p53 in tumorigenesis. Semin. Cancer Biol. 11, 23-30
86. Abbas, T., White, D., Hui, L., Yoshida, K., Foster, D. A., and Bargonetti, J. (2004) Inhibition of human p53 basal transcription by down-regulation of protein kinase C δ. J. Biol. Chem. 279 In press
87. Zhong, M., Lu, Z., and Foster, D. A. (2002) Down-regulating PKC δ provides a PI3K/Akt-independent survival signal that overcomes apoptotic signals generated by c-Src overexpression. Oncogene 21, 1071-1078
88. Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., and Weichselbaum, R. (1995) Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO J. 14, 6148-6156
89. Ghayur, T., Hugunin, M., Talanian, R. V., Ratnofsky, S., Quinlan, C., Emoto, Y., Pandey, P., Datta, R., Huang, Y., Kharbanda, S., et al. (1996) Proteolytic activation of protein kinase C δ by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 184, 2399-2404
90. Ren, J., Datta, R., Shioya, H., Li, Y., Oki, E., Biedermann, V., Bharti, A., and Kufe, D. (2002) p73β is regulated by protein kinase Cδ catalytic fragment generated in the apoptotic response to DNA damage. J. Biol. Chem. 277, 33758-33765
91. Li, C., Wernig, F., Leitges, M., Hu, Y., and Xu, Q. (2003) Mechanical stress-activated PKCδ regulates smooth muscle cell migration. FASEB J.
92. Huppi, K., Siwarski, D., Goodnight, J., and Mischak, H. (1994) Assignment of the protein kinase Cδ polypeptide gene (PRKCD) to human chromosome 3 and mouse chromosome 14. Genomics 19, 161-162
93. Zabarovsky, E. R., Lerman, M. I., and Minna, J. D. (2002) Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21, 6915-6916
94. Yang, Q., Yoshimura, G., Mori, I., Sakurai, T., and Kakudo, K. (2000) Chromosome 3p and breast cancer. J. Hum. Genet. 47, 453-459
95. Clark, A. S., West, K. A., Blumberg, P. M., and Dennis, P. A. (2003) Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCδ promotes cellular survival and chemotherapeutic resistance. Cancer Res. 63, 780-786
96. Ni, H., Ergin, M., Tibudan, S. S., Denning, M. F., Izban, K. F., and Alkan, S. (2003) Protein kinase C-δ is commonly expressed in multiple myeloma cells and its downregulation by rottlerin causes apoptosis. Br. J. Haematol. 121, 849-856
97. Ren, J., Li, Y., and Kufe, D. (2002) Protein kinase C δ regulates function of the DF3/MUC1 carcinoma antigen in β-catenin signaling. J. Biol. Chem. 277, 17616-17622